Location:
Japan

Specialty:
Interventional Radiologists

Quant study:
Market Opportunity for an Endovascular Device

Sample:
284

Skipping the Panel: How We Reached Japan's Liver Specialists

Most physician surveys start with a commercial panel. This one didn't.

We needed to know how Japanese doctors would respond to a new device for TIPS, a procedure that treats complications of portal hypertension. If you ask the wrong doctors, you get the wrong answer. Commercial recruitment lists have hidden skews. Some lean towards one region. Others come from an old conference list dominated by one type of physician, often older doctors in small hospitals who are slower to take up new therapies. We would never have known how far the sample drifted from the national picture.

So we went to the source. Two professional bodies, the Japanese Society of Interventional Radiology and the Japanese Society for Portal Hypertension, checked the survey design, built the sampling frame and invited their own members.

Each society filtered its membership down to heads of department at the hospitals most likely to perform TIPS. That meant 341 interventional radiologists and 106 hepatologists and gastroenterologists. Each was invited three times over a 2.5-week window to complete a 10-minute online survey in Japanese.

The response was strong: 284 physicians took part. We screened out 53 who leave treatment decisions to other specialists. That left 231 who perform or decide on portal hypertension treatment:

  • 142 interventional radiologists

  • 63 hepatologists

  • 17 gastroenterologists

  • 9 surgeons

On the hepatology side, three in four of the doctors invited completed the survey.

The result a clean, focused sample of likely early adopters, the doctors who would pick up a new device first. Making the sample the best available baseline for judging real demand, rather than the average opinion of whoever happened to be on a list.

Want to learn more?

Next
Next

US: Patients (Ethnographic n=30)